Review

Published on 29 Jun 2021

Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials

in Respiratory Pharmacology

Hong Chen
Jian Sun
Qiang Huang
Yongqi Liu
Mengxin Yuan
Chunlan Ma
Hao Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.691621

8,714 views
26 citations

Review

Published on 29 Jun 2021

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19

in Respiratory Pharmacology

Shengguang Wang
Zhen Li
Xinyu Wang
Shiming Zhang
Peng Gao
Zuorong Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.698905

22,671 views
41 citations

Original Research

Published on 28 Jun 2021

Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation

in Respiratory Pharmacology

Yanmin Zhao
Guifang OuYang
Jimin Shi
Yi Luo
Yamin Tan
Jian Yu
Huarui Fu
Xiaoyu Lai
Lizhen Liu
He Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.668825

5,912 views
15 citations

Original Research

Published on 23 Jun 2021

Systemic Administration of Tempol Attenuates the Cardiorespiratory Depressant Effects of Fentanyl

in Respiratory Pharmacology

Santhosh Baby
Ryan Gruber
Joseph Discala
Veljko Puskovic
Nijo Jose
Feixiong Cheng
Michael Jenkins
James Seckler
Stephen Lewis

Frontiers in Pharmacology

doi 10.3389/fphar.2021.690407

3,427 views
20 citations

Original Research

Published on 23 Jun 2021

Allergic Asthma-Induced Cognitive Impairment is Alleviated by Dexamethasone

in Respiratory Pharmacology

Mengli Ren
Min Feng
Zhimin Long
Jing Ma
Xuehua Peng
Guiqiong He

Frontiers in Pharmacology

doi 10.3389/fphar.2021.680815

12,560 views
21 citations

Original Research

Published on 18 Jun 2021

Exploring the Mechanism Whereby Sinensetin Delays the Progression of Pulmonary Fibrosis Based on Network Pharmacology and Pulmonary Fibrosis Models

in Respiratory Pharmacology

Yong Xu
Wen-Lu Hang
Xian-Mei Zhou
Qi Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.693061

3,976 views
12 citations

Original Research

Published on 17 Jun 2021

Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation

in Respiratory Pharmacology

Ting Xiao
Mengqi Cui
Caijuan Zheng
Ming Wang
Ronghao Sun
Dandi Gao
Jiali Bao
Shanfa Ren
Bo Yang
Jianping Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2021.669642

8,594 views
69 citations

Original Research

Published on 17 Jun 2021

Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences

in Respiratory Pharmacology

Elena Campione
Caterina Lanna
Terenzio Cosio
Luigi Rosa
Maria Pia Conte
Federico Iacovelli
Alice Romeo
Mattia Falconi
Claudia Del Vecchio
Elisa Franchin

Frontiers in Pharmacology

doi 10.3389/fphar.2021.666600

16,666 views
72 citations

Review

Published on 14 Jun 2021

Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021

in Respiratory Pharmacology

Safaet Alam
Taslima Binte Kamal
Md. Moklesur Rahman Sarker
Jin-Rong Zhou
S. M. Abdur Rahman
Isa Naina Mohamed

Frontiers in Pharmacology

doi 10.3389/fphar.2021.659577

16,317 views
35 citations

Original Research

Published on 11 Jun 2021

AGR3 Regulates Airway Epithelial Junctions in Patients with Frequent Exacerbations of COPD

in Respiratory Pharmacology

Rui Ye
Cuihong Wang
Pengbo Sun
Shuang Bai
Li Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2021.669403

2,727 views
9 citations

Original Research

Published on 08 Jun 2021

Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR

in Respiratory Pharmacology

Jie Wang
Yan Ren
Xiufen Zheng
Jiaqi Kang
Zhenqian Huang
Lizhi Xu
Yaping Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.675907

3,405 views
10 citations

Review

Published on 07 Jun 2021

Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential

in Respiratory Pharmacology

Xinyu Cui
Wuyue Chen
Haoyan Zhou
Yuan Gong
Bowen Zhu
Xiang Lv
Hongbo Guo
Jinao Duan
Jing Zhou
Edyta Marcon

Frontiers in Pharmacology

doi 10.3389/fphar.2021.664349

71,928 views
51 citations

Original Research

Published on 28 May 2021

Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension

in Respiratory Pharmacology

Alexandre Todorovic Fabro
Juliana Machado-Rugolo
Camila Machado Baldavira
Tabatha Gutierrez Prieto
Cecília Farhat
Flavia Regina Rotea ManGone
Sabrina Setembre Batah
Heloísa Resende Cruvinel
Maiara Almeida Aldá
Jhonatas Sirino Monteiro

Frontiers in Pharmacology

doi 10.3389/fphar.2021.648769

5,119 views
11 citations

Original Research

Published on 14 May 2021

Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells

in Respiratory Pharmacology

Zsolt Bene
Zsolt Fejes
Tibor Gabor Szanto
Ferenc Fenyvesi
Judit Váradi
Luka A. Clarke
Gyorgy Panyi
Milan Macek
Margarida D. Amaral
István Balogh

Frontiers in Pharmacology

doi 10.3389/fphar.2021.592184

3,511 views
10 citations

Original Research

Published on 04 May 2021

The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome

in Respiratory Pharmacology

Pamela Nithzi Bricher Choque
Rodolfo P. Vieira
Luis Ulloa
Caren Grabulosa
Maria Claudia Irigoyen
Katia De Angelis
Ana Paula Ligeiro De Oliveira
Kevin J. Tracey
Valentin A. Pavlov
Fernanda Marciano Consolim-Colombo

Frontiers in Pharmacology

doi 10.3389/fphar.2021.624895

6,874 views
10 citations

Review

Published on 30 Apr 2021

Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation

in Respiratory Pharmacology

Ming Cai
Xuan Chen
Jieling Shan
Ruoyu Yang
Qi Guo
Xia Bi
Ping Xu
Xiangrong Shi
Lixi Chu
Liyan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.643619

11,112 views
13 citations

Navigation group

Articles

Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19

Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation

Systemic Administration of Tempol Attenuates the Cardiorespiratory Depressant Effects of Fentanyl

Allergic Asthma-Induced Cognitive Impairment is Alleviated by Dexamethasone

Exploring the Mechanism Whereby Sinensetin Delays the Progression of Pulmonary Fibrosis Based on Network Pharmacology and Pulmonary Fibrosis Models

Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation

Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences

Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021

AGR3 Regulates Airway Epithelial Junctions in Patients with Frequent Exacerbations of COPD

Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR

Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential

Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension

Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells

The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome

Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation